Is Caris Life Sciences, Inc. (CAI) a Buy, Sell, or Hold?
NASDAQ : CAI
Caris Life Sciences, Inc. — Institutional Ownership
$15.59 USD
$0 (0.0%)
- Volume
- 5.58M
- Average Volume
- 3.16M
- Market Capitalization
- $4.41B
- P/E Ratio
- -10.02
- Dividend Yield
- 0.00%
- Price Target
- $23.50
- Year High
- $42.50
- Year Low
- $14.19
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.05
Institutional Ownership Summary
Institutional Ownership %
0.50%
Investors Holding
40
change: -168 | last: 208
Increased Positions
27
change: -120 | last: 147
Reduced Positions
9
change: -28 | last: 37
New Positions
12
change: -44 | last: 56
Sold Positions
174
change: 134 | last: 40
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -113.4098 | last: 1.1341
Total Invested
24.89M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-12 | J H Whitney VI L P | 18.26M | 6.50% |
| 2026-05-12 | TSSP Sub-Fund HoldCo, LLC | 13.67M | 4.80% |
| 2026-04-07 | FMR LLC | 30.63M | 10.80% |
| 2026-02-13 | TSSP Sub-Fund HoldCo, LLC | 18.42M | 6.50% |
| 2026-02-05 | FMR LLC | 14.14M | 5.00% |
| 2025-08-14 | J H Whitney VI LP | 20.26M | 7.30% |
| 2025-08-13 | David D. Halbert | 124.91M | 44.10% |
| 2025-07-28 | TSSP Sub-Fund HoldCo, LLC | 23.17M | 8.30% |
| 2025-06-24 | Riverview Group LLC | 2.99M | 1.10% |
CAI Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $26.98 | 1.67B | $45.11B | $797.8M | $378.99M | $44.69B |
| 2024-12-31 | $28.00 | 254.66M | $7.13B | $63.95M | $424.26M | $7.49B |
| 2023-12-31 | $28.00 | 254.66M | $7.13B | $56.4M | $217.27M | $7.29B |
| 2022-12-31 | $28.00 | 254.79M | $7.13B | $107.19M | $270.87M | $7.3B |
| 2020-12-31 | $28.00 | 17.95M | $502.57M | $53.55M | $1.75B | $2.19B |
| 2019-12-31 | $28.00 | 18.01M | $504.31M | $46.46M | $2.1B | $2.56B |
| 2018-12-31 | $28.00 | 19.82M | $554.9M | $45.32M | $2.16B | $2.67B |
| 2017-12-31 | $28.00 | 19.25M | $539.08M | $35.42M | $1.7B | $2.21B |
| 2016-12-31 | $28.00 | 19.32M | $540.9M | $46.13M | $1.48B | $1.97B |
| 2015-12-31 | $28.00 | 20.77M | $581.64M | $52.55M | $1.43B | $1.96B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17.88 | 282.56M | $5.05B | $821.15M | $430.96M | $4.66B |
| 2025-12-31 | $26.98 | 1.67B | $45.11B | $797.8M | $378.99M | $44.69B |
| 2025-09-30 | $30.25 | 282.1M | $8.53B | $753.22M | $426.74M | $8.21B |
| 2025-06-30 | $26.72 | 268.44M | $7.17B | $718.93M | $418.98M | $6.87B |
| 2025-03-31 | $28.00 | 254.79M | $7.13B | $31.2M | $419.83M | $7.52B |
| 2024-06-30 | $28.00 | 254.79M | $7.13B | -$ | -$ | $7.13B |
| 2024-03-31 | $28.00 | 254.79M | $7.13B | -$ | -$ | $7.13B |
| 2021-09-30 | $28.00 | 17.34M | $485.44M | $47.03M | $2.26B | $2.7B |
| 2021-06-30 | $28.00 | 17.28M | $483.87M | $38.81M | $1.82B | $2.27B |
| 2021-03-31 | $28.00 | 17.27M | $483.59M | $47.91M | $1.83B | $2.26B |
| 2020-12-31 | $28.00 | 17.71M | $495.91M | $53.55M | $1.75B | $2.19B |
| 2020-09-30 | $28.00 | 17.57M | $491.96M | $42.3M | $2.21B | $2.66B |